Language Disorders: Clinical Trials

10 trials for Language Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 10
Phase 22Completed 2

Follow Language Disorders: new trials by email Literature Review of Language Disorders trials Research Report on Language Disorders

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Precision Medicine Approach, Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises, Standard-of-Care - Mild Cognitive Impairment, Dementia, Mild
Phase 3CompletedAlzheimer's Prevention and Reversal Project, Inc.732023-07-312026-02-18
Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
Donepezil, Intensive-Language Action Therapy, Transcranial direct current stimulation - Aphasia, Stroke
Phase 3CompletedUniversity of Malaga202019-01-082020-11-05
Use of Local Intraoperative Steroid in MIS TLIF
Methylprednisolone, Dexamethasone - Dysphasia
Phase 3CompletedRush University Medical Center1052015-11-132020-11-20
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Placebo, AM-111 0.4 mg/ml, AM-111 0.8 mg/ml - Hearing Loss
Phase 3CompletedAuris Medical AG2562015-11-012023-09-14
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
pagoclone, placebo - Stuttering
Phase 2 / Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company3212009-02-012012-08-28
Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia
Melodic Intonation Therapy, Speech-Repetition-Therapy - Aphasia, Stroke
Phase 3CompletedBeth Israel Deaconess Medical Center302008-02-012020-09-21
Augmenting Language Therapy for Aphasia: Levodopa
levodopa/carbidopa, Placebo comparator - Nonfluent Aphasia, Stroke
Phase 2 / Phase 3CompletedShirley Ryan AbilityLab362007-10-012013-12-25
A Comparison of Language Intervention Programs
Fast ForWord, Computer Assisted Language Intervention, Individual Language Intervention - Language Disorders
Phase 3CompletedNational Institute on Deafness and Other Communication Disorders (NIDCD)2162002-06-012006-04-24
Treatment of Childhood Social Phobia
Social Effectiveness Therapy for Children (SET-C), Fluoxetine, Pill Placebo - Social Phobia
Phase 3CompletedUniversity of Central Florida1392001-04-012013-08-01
Reading Problems in Children Living in Urban Areas
Reading Instruction - Dyslexia
Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)14001993-07-012015-06-03

Narrower conditions

Aphasia (4)  ·  Stroke (3)  ·  Speech Disorders (2)  ·  Alzheimer Disease (1)  ·  Anomia (1)  ·  Aphasia, Broca (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cerebral Infarction (1)  ·  Cerebrovascular Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Deafness (1)  ·  Dementia (1)  ·  Dyslexia (1)  ·  Ear Diseases (1)

Broader conditions

Communication Disorders (10)  ·  Nervous System Diseases (10)  ·  Neurobehavioral Manifestations (10)  ·  Neurologic Manifestations (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (9)  ·  Speech Disorders (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Mental Disorders (4)  ·  Cardiovascular Diseases (3)  ·  Neurodevelopmental Disorders (3)  ·  Vascular Diseases (3)  ·  Cerebrovascular Disorders (2)

Interventions

D-JNKI-1 (1)  ·  Dexamethasone (1)  ·  Donepezil (1)  ·  Exercise (1)  ·  Fluoxetine (1)  ·  Hormones (1)  ·  Methylprednisolone (1)  ·  Standard of Care (1)  ·  Transcranial Direct Current Stimulation (1)  ·  carbidopa, levodopa drug combination (1)  ·  pagoclone (1)

Sponsors

Alzheimer's Prevention and Reversal Project, Inc. (1)  ·  Auris Medical AG (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  National Institute on Deafness and Other Communication Disorders (NIDCD) (1)  ·  Rush University Medical Center (1)  ·  Shirley Ryan AbilityLab (1)  ·  University of Central Florida (1)  ·  University of Malaga (1)

Countries

United States (6)  ·  Bulgaria (1)  ·  Spain (1)

Top investigators

Andrea Norton, BM (1)  ·  Barbara R. Foorman (1)  ·  Dale Bredesen, MD (1)  ·  Gottfried Schlaug, MD, PhD (1)  ·  Kat Toups, MD (1)  ·  Kern Singh, MD (1)  ·  Marcelo L Berthier, MD, PhD (1)  ·  Ronald Gillam, PhD (1)

Results publications

PMID 18030084, PMID 19673813, PMID 20013046, PMID 21197418, PMID 21391024, PMID 30497132, PMID 35433325

NIH funding

R01DC008796 (1), R01HD030995 (1), R01MH053703 (1)